Objective: To achieve the full potential of sentinel lymph node (SLN) detection in endometrial cancer, both presumed low- and high-risk groups should be included. Perioperative resource use and complications should be minimized. Knowledge on distribution and common anatomical sites for metastatic SLNs may contribute to optimizing the concept while maintaining sensitivity. Proceeding from previous studies, simplified algorithms based on histology and lymphatic anatomy are proposed.
Methods: Data on mapping rates and locations of pelvic SLNs (metastatic and non-metastatic) from two previous prospective SLN studies in women with endometrial cancer were retrieved. Cervically injected indocyanine green was used as a tracer and an ipsilateral re-injection was performed in case of non-display of the upper and/or lower paracervical pathways. A systematic surgical algorithm was followed with clearly defined SLNs depicted on an anatomical chart. In high-risk endometrial cancer patients, removal of SLNs was followed by a pelvic and para-aortic lymphadenectomy.
Results: 423 study records were analyzed. The bilateral mapping rates of the upper and lower paracervical pathways were 88.9% and 39.7%, respectively. 72% of all SLNs were typically positioned along the upper paracervical pathway (interiliac and/or proximal obturator fossa) and 71 of 75 (94.6%) of pelvic node positive women had at least one metastatic SLN at either of these positions. Women with grade 1-2 endometroid cancers (n=275) had no isolated metastases along the lower paracervical pathway compared with two women with high-risk histologies (n=148).
Conclusion: SLNs along the upper paracervical pathway should be identified in all endometrial cancer histological subtypes; removal of nodes at defined typical positions along the upper paracervical pathway may replace a site-specific lymphadenectomy in case of non-mapping despite tracer re-injection. Detection of SLNs along the lower paracervical pathway can be restricted to high-risk histologies and a full pre-sacral lymphadenectomy should be performed in case of non-display.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/ijgc-2019-000935 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
A prospective study evaluating an optimized sentinel node algorithm in early stage cervical cancer: The PROSACC-study.
Gynecol Oncol
August 2024
Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Skåne University Hospital, Lund University, Faculty of Medicine, Department of Clinical Sciences, Obstetrics and Gynecology, 22185 Lund, Sweden.
Objective: A single center prospective non-randomized study to assess a systematically developed anatomically-based sentinel lymph node (SLN) algorithm in cervical cancer.
Methods: Consecutive women with FIGO 2009 stage 1A2-2A1 cervical cancer undergoing robotic radical hysterectomy/trachelectomy between September 2014 and January 2023 had cervically injected Indocyanine Green (ICG) as a tracer for detection of pelvic SLN. An anatomically based surgical algorithm was adhered to; defining SLNs as the juxtauterine mapped nodes within the upper and lower paracervical lymphatic pathways including separate removal of the parauterine lymphovascular tissue (PULT).
A selective anatomically based lymph node sampling can replace a side specific pelvic lymphadenectomy in endometrial cancer with failed sentinel node mapping.
Eur J Cancer
June 2024
Department of Obstetrics and Gynaecology, Division of Gynaecologic Oncology, Skåne University Hospital Lund, Lund University Faculty of Medicine, Department of Clinical Sciences, Obstetrics and Gynaecology, Lund, Sweden. Electronic address:
Aim: To evaluate the locations of metastatic pelvic sentinel nodes (SLN) and the proportion of SLNs outside and within defined typical anatomical positions along the upper paracervical lymphatic pathway (UPP).
Patients And Methods: Consecutive women with endometrial cancer (EC) of all risk groups underwent pelvic SLN-detection using cervically injected indocyanine green (ICG). A strict anatomically based algorithm and definitions of SLNs was adhered to.
En Bloc Resection of Sentinel Lymph Nodes with the Hysterectomy Specimen in Endometrial Cancer.
Ann Surg Oncol
July 2024
Poole Hospital, University Hospitals Dorset NHS Foundation Trust, Poole, UK.
Objective: We demonstrate the surgical technique of removing the sentinel lymph nodes with its afferent lymphatic vessels attached to the hysterectomy specimen.
Design: Stepwise demonstration of the technique with narrated video footage.
Setting: Sentinel lymph node sampling has been established as an acceptable staging method in endometrial cancer cases.
Comparison of sentinel lymph node distribution and lymphatic drainage pathway between high- and low-risk endometrial cancers.
Arch Gynecol Obstet
November 2023
Department of Obstetrics and Gynecology, Peking University People's Hospital, Beijing, China.
Article Synopsis
- The study compared the distribution and drainage pathways of sentinel lymph nodes (SLN) in patients with high-risk versus low-risk endometrial cancer, analyzing 429 cases from a hospital in Beijing.
- Findings showed that using both indocyanine green (ICG) and carbon nanoparticles (CNP) significantly improved SLN detection rates.
- The research concluded that while upper paracervical pathway detection is crucial for both risk groups, lower paracervical pathway detection is particularly important for low-risk patients, emphasizing the need for targeted lymph node removal in high-risk cases.
Unilateral hydroureteronephrosis after introduction of a levonorgestrel-releasing intrauterine system: a case report and literature review.
Minerva Obstet Gynecol
October 2023
Department of Molecular and Developmental Medicine, Obstetrics and Gynecological Clinic, University of Siena, Siena, Italy.
Insertion of a LNG-Intra-uterine System (LNG-IUS) has many gynecological indications. The approved indications worldwide are contraception, treatment of abnormal uterine bleeding depending on not organic disease, and endometrial protection in case of an estrogenic therapy. Instead adenomyosis, fibroids, and fertility-sparing management of endometrial hyperplasia or early endometrial cancer in patients with desire of pregnancy are off label indications.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!